Randox Pharma Services have developed Biochip Array Technology, a multiplex technology, which allows the simultaneous detection of multiple biomarkers from a single patient sample. Given the increased value of multiple biomarkers to improve patient diagnosis, such a technology is the ideal “target platform” for translational science. Already arrays have been developed which are applicable to a broad range of therapeutic areas, with applications including multiplex immunoassays and nucleic acid based SNP, mutation, gene expression, and pathogen detection arrays.

Randox Pharma Services also offer over 130 enzymatic, substrate and immunoturbidimetric assays on our class-leading range of RX Series chemistry analysers which provide quality results at every phase from preclinical testing through to the clinic.